| Product Code: ETC7538779 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India bronchiolitis drugs market import shipment experienced a significant decline with a CAGR of -26.9% from 2020 to 2024. The growth rate between 2023 and 2024 was even more pronounced at -50.0%, indicating a sharp contraction in market activity. The market has been steadily slowing down over the years, showing a clear trend of decline and loss of momentum.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Bronchiolitis Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Bronchiolitis Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Bronchiolitis Drugs Market - Industry Life Cycle |
3.4 India Bronchiolitis Drugs Market - Porter's Five Forces |
3.5 India Bronchiolitis Drugs Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 India Bronchiolitis Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 India Bronchiolitis Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 India Bronchiolitis Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Bronchiolitis Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Bronchiolitis Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Bronchiolitis Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 High prevalence of bronchiolitis in India |
4.2.2 Increasing awareness about bronchiolitis symptoms and treatment options |
4.2.3 Growing healthcare infrastructure and access to medical facilities in India |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 Competition from alternative treatment options such as home remedies or traditional medicine |
5 India Bronchiolitis Drugs Market Trends |
6 India Bronchiolitis Drugs Market, By Types |
6.1 India Bronchiolitis Drugs Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 India Bronchiolitis Drugs Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 India Bronchiolitis Drugs Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 India Bronchiolitis Drugs Market Revenues & Volume, By Antiviral drugs, 2021- 2031F |
6.1.5 India Bronchiolitis Drugs Market Revenues & Volume, By Aerosolized ribavirin, 2021- 2031F |
6.1.6 India Bronchiolitis Drugs Market Revenues & Volume, By Bronchodilators, 2021- 2031F |
6.1.7 India Bronchiolitis Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.8 India Bronchiolitis Drugs Market Revenues & Volume, By Oxygen Therapy, 2021- 2031F |
6.2 India Bronchiolitis Drugs Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 India Bronchiolitis Drugs Market Revenues & Volume, By Viral Bronchiolitis, 2021- 2031F |
6.2.3 India Bronchiolitis Drugs Market Revenues & Volume, By Bronchiolitis Obliterans, 2021- 2031F |
6.3 India Bronchiolitis Drugs Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 India Bronchiolitis Drugs Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 India Bronchiolitis Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.4 India Bronchiolitis Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Bronchiolitis Drugs Market Revenues & Volume, By Inhalational, 2021- 2031F |
6.4.3 India Bronchiolitis Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 India Bronchiolitis Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5 India Bronchiolitis Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Bronchiolitis Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 India Bronchiolitis Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 India Bronchiolitis Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6 India Bronchiolitis Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Bronchiolitis Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Bronchiolitis Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 India Bronchiolitis Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Bronchiolitis Drugs Market Import-Export Trade Statistics |
7.1 India Bronchiolitis Drugs Market Export to Major Countries |
7.2 India Bronchiolitis Drugs Market Imports from Major Countries |
8 India Bronchiolitis Drugs Market Key Performance Indicators |
8.1 Number of healthcare facilities offering bronchiolitis treatment |
8.2 Adoption rate of advanced bronchiolitis drugs in India |
8.3 Investment in research and development for bronchiolitis drugs in the country |
9 India Bronchiolitis Drugs Market - Opportunity Assessment |
9.1 India Bronchiolitis Drugs Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 India Bronchiolitis Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 India Bronchiolitis Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 India Bronchiolitis Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Bronchiolitis Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Bronchiolitis Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Bronchiolitis Drugs Market - Competitive Landscape |
10.1 India Bronchiolitis Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Bronchiolitis Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here